Either way, you cannot simply use the same milligram dose
Medical Disclaimer This content is for informational purposes only and does not replace professional medical advice
SURMOUNT-1 Trial (New England Journal of Medicine, 2022) Randomized, double-blind, placebo-controlled 2,539 participants 72 weeks NCT04184622 Tirzepatide 5 mg -16.0% Mean body weight reduction Tirzepatide 10 mg -21.4% Mean body weight reduction Tirzepatide 15 mg -22.5% Mean body weight reduction Placebo group: -2.4% All results statistically significant (p 27 with Comorbidities Overweight or obese patients (Indian cutoff BMI 23+ with risk factors) seeking significant, sustained weight loss
If youre experiencing excessive shedding, consult a dermatologist or endocrinologist to evaluate nutritional status, hormone levels, and hair health
The absence of formal contraindication does not equate to established safety or efficacy for combined use
One reason researchers frequently compare BPC-157 and TB-500 is that their biological characteristics appear complementary rather than identical